Cyberonics posts record sales in fiscal '13; Bacterin raising $4.9M;

@FierceMedDev: NeuroMetrix preferred stock placement pulls in $5M. Item | Follow @FierceMedDev

@DamianFierce: Amid efficacy worries from the FDA, Abbott posted more positive results for MitralClip. Report | Follow @DamianFierce

@MarkHFierce: Our latest special report - a closer look at six device and Dx startups making waves. Feature | Follow @MarkHFierce

> Cyberonics ($CYBX) posted record sales of $254 million last fiscal year, a 16% jump over 2012, and net income rose 28% to $46.4 million. Results

> Providence Medical Technology in San Francisco won the FDA's 510(k) clearance for its PMT cervical cage, a minimally invasive implant and drug delivery system for cervical fusion procedures. Item

> Bacterin ($BONE) is looking to raise about $4.9 million in a stock sale, money the company will use on operating expenses and working capital. News

> The Department of Health and Human Services has authorized the FDA to fast-track approval for diagnostics that detect Middle East respiratory syndrome coronavirus, which the feds have deemed a threat to public health and national security. Article

> Cohera Medical has completed enrollment in an FDA-targeted study of TissuGlu, an internal adhesive designed to stick to tissue flaps during surgery. The company raised $17 million in venture cash in February to fund the device's development. More

> Echo Therapeutics ($ECTE) has launched a CE mark trial for Symphony CGM, a non-invasive continuous glucose monitor. Release

> Vycor Medical says it has obtained yet another patent for its 510(k) cleared NovaVision device designed to help restore neurologically induced vision loss. Item

Biotech News

@FierceBiotech: ICYMI: NIH lays out effects of sequestration on biomedical research. Article | Follow @FierceBiotech

@JohnCFierce: Aveo slashes 140 jobs, halts R&D work related to doomed FDA drug application. News | Follow @JohnCFierce

@RyanMFierce: GenoSpace joins growing alliance for sharing translational research data. Article | Follow @RyanMFierce

@EmilyMFierce: More New Yorkers skipping vaccines on religious grounds. Story | Follow @EmilyMFierce

> Can India's Biocon land a global partner for its new psoriasis drug? More

> Johnson & Johnson takes rare gamble on microbiome science of biotech startup. News

> J&J pitches plan to spawn new biotechs, strike deals in San Francisco. Article

Pharma News

@FiercePharma: Swedish drugmaker Meda says it's not in buyout talks. Sun Pharma had reportedly been eyeing a deal. More | Follow @FiercePharma

@EricPFierce: FDA tells Novartis in warning letter it doesn't like what it sees at Austria plant, particles in vials. More | Follow @EricPFierce

@CarlyHFierce: India's officials have been tough on Big Pharma but may now resurrect Pfizer's Sutent patent. Article | Follow @CarlyHFierce

> Sky-high drug prices will force change in cancer care, experts say. Story

> Novartis' Sandoz unit stumbles again. Report

> Meda responds to Sun buyout reports with firm 'no deal.' Article

Drug Delivery News

@MichaelGFierce: Novel oral drugs spur big investments for Akebia, Protagonist. Article | Follow @MichaelGFierce

> Hydrogels deliver immuno drugs to transplanted hands. Story

> Janssen Labs-based Arcturus gets $1.3M boost for RNAi delivery tech. Item

> In study, nasal spray cuts addictive binge eating in obese patients. More

> Nanoparticles release chemo when activated with red light. Story

Suggested Articles

In an SEC filing, Baxter International disclosed that it may have overstated its income over multiple years, inflating it by about $276 million.

The FDA has given Grail a green light to conduct the interventional study, and it has begun enrolling participants through the company’s R&D partners.

Coronavirus may not require a front-line battle yet in certain places, but it’s still taxing public health officials preparing for a potential crisis.